Cannabidiol, the experimental marijuana drug, has been gaining favor in the medical world for a wide range of patients but a new case study coming out of Georgia is breaching unprecedented territory.
Doctors of the Georgia Regent University in Augusta are supplying cannabidiol to a seven-year-old Preston Weaver as he suffers from Lennox-Gastaut syndrome, a debilitating disease that has left him blind, mute and crippled.
Raw Story has learned that young Preston is part of a program that includes 50 children with Lennox-Gastaut syndrome being placed on a trial run of the branded drug Epidiolex, which contains cannabidiol. Before any of you outraged parents begin the picket the weed wagon, know that the amount of cannabidol found in Epidiolex doesn’t give patients a recreational high, and is known as a “compassionate use” when it comes to taking it.
Epidiolex isn’t approved by the FDA but Georgia Governor Nathan Deal approved the trial run, giving it a large boost in credibility for future treatments. The governor spoke to ABC News and he gave his reasoning stating, “No one with a heart could hear the stories of these children and their parents and not want to exhaust every possibility to provide them with the treatment they need to combat this debilitating condition.”
Preston’s mother, Valarie Weaver, also expressed her happiness with the drug that helps not only her son but all kids who are dire need of the marjiuana’s healing powers. “Our hope is that this treatment will calm down his brain enough so that he will start communicating with us,” she reinterated with ABC News. “This is the first day of the rest of his life,” Weaver told WRDW.com. “I’m just completely overjoyed he was chosen to get this. We’re just completely blessed.”
Check out Preston get his first dose of Epidiolex in the gallery below. For more information on the experimental drug, visit GWPHarm.com/Epiolex.